"ANPHARM" PRZEDSIĘBIORSTWO FARMACEUTYCZNE SPÓŁKA AKCYJNA
UL. ANNOPOL 6B, 03-236 WARSZAWA
TAX ID1180059253
Rate company:
ALEO.com Companies Pharmacy, medicine and cosmetics Medicines and supplements Profile of company "ANPHARM" PRZEDSIĘBIORSTWO FARMACEUTYCZNE SPÓŁKA AKCYJNA
"ANPHARM" PRZEDSIĘBIORSTWO FARMACEUTYCZNE SPÓŁKA AKCYJNA
TAX ID1180059253
KRS0000025198
Share capital7,892,148.00 zł
No opinion. Add your first review

address

UL. ANNOPOL 6B, 03-236 WARSZAWA

Website

www.anpharm.pl
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Dołącz do ALEO.com

Register Data

Full name

"ANPHARM" PRZEDSIĘBIORSTWO FARMACEUTYCZNE SPÓŁKA AKCYJNA

Copy
uses securityreCAPTCHA

Legal address

UL. ANNOPOL 6B, 03-236 WARSZAWA

NIP

1180059253
Copy

REGON

010421975
Copy

KRS

0000025198
Copy

Legal form

joint stock company

Register Address

UL. ANNOPOL 6B, 03-236 WARSZAWA

Date of registration in KRS

2001-07-09

Date of commencement of economic activity

2001-07-09

Act signature

RDF/593974/24/602

Website

WWW.ANPHARM.PL

Pkd codes

21.20.Z - Manufacture of medicines and other pharmaceutical products

35.30.Z - Steam, hot water and air conditioning manufacturing and supply

82.92.Z - Packaging activities


Active
Vat list bank account(s)

Company authorities

representation authorityMANAGEMENT
supervisory authorityboard of directors
representation type
KAŻDY CZŁONEK ZARZĄDU MA PRAWO DO SAMODZIELNEGO REPREZENTOWANIA SPÓŁKI.
MANAGEMENT
Philippe Dartiguelongue
Member Of The Board, 59 years old
proxies
Jolanta Brzęczek
total, 64 years old
Grzegorz Trębiński
total with other proxy, 45 years old
Jérôme Charles Joseph Schneeberger
spontaneous, 47 years old
BOARD OF DIRECTORS
Pierre Charles Venesque
Jean-luc Jacques Thomas
Stephane Mascarau

Financial data

Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
2019 2020 2021
M PLN
M PLN
M PLN
%
Net sales Indicator description
568,5
602,6
491,2
-18,5
Liabilities and provisions Indicator description
212,2
270,7
184,4
-31,9
Equity Indicator description
161,8
158,8
191,5
20,7
Total assets Indicator description
373,9
429,4
375,9
-12,5
Cash and cash equivalents Indicator description
68,1
83
55,8
-32,8
Gross profit / loss Indicator description
41,3
39,3
40,7
3,6
Operating profit (EBIT) Indicator description
40,6
40
40,9
2,4
Net profit / loss Indicator description
33,4
31,7
32,8
3,4
Current assets Indicator description
301,8
344,9
282,1
-18,2
%
%
%
p.p.
Return on sales (ROS) Indicator description
5,9
5,3
6,7
1,4
Equity ratio Indicator description
43,3
37
51
14
Gross profit margin Indicator description
7,3
6,5
8,3
1,8
Days
Days
Days
Days
Current liabilities turnover ratio Indicator description
134
161
134
-27
Current ratio Indicator description
1,4
1,3
1,6
0,3
See more

Financial statements

01-10-2022 - 30-09-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf

01-10-2022 - 30-09-2023
Annual financial report
Download pdf

01-10-2022 - 30-09-2023
Activity report
Download pdf
Show more (2)
uses security  reCAPTCHA

Opinions

Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.

0/ 5.0
How do you rate this company?
Your opinion matters to us.

Companies registered in the same sector